Hot Stock's Trend Recap – Heat Biologics Inc (NASDAQ: HTBX) – Alpha Beta Stock

This post was originally published on this site

U.S. stocks ended lower on Tuesday as the closely-watched 10-year Treasury yield reached new highs.

The Dow Jones Industrial Average lost 193 points, or 0.78 percent, to 24,706.41. The S&P 500 erased 18.68 points, or 0.68 percent, to 2,711.45. The Nasdaq Composite Index was down 59.69 points, or 0.81 percent, to 7,351.63.

The benchmark 10-year Treasury yield hit 3.09 percent on Tuesday, its highest level since 2011.

The yield, a barometer for mortgage rates and other financial instruments, has jumped recently on signs of rising inflation, which sparked market speculation for more rate hikes later this year.

The probability that the U.S. central bank will raise its benchmark rate a fourth time this year went above 50 percent for the first time, according to the CME’s FedWatch tracking tool for the fed funds futures market.

Analysts said shareholders also worried that the climbing borrowing costs may slow the economy. A move in the yield above 2.9 percent earlier this year triggered a correction for U.S. equities.

On the economic front, advance estimates of U.S. retail and food services sales for April were 497.6 billion U.S. dollars, a boost of 0.3 percent from the previous month, in line with market expectations, said U.S. Commerce Department on Tuesday. (Source: Xinhua)

Top Pick for Wednesday: Heat Biologics Inc (NASDAQ: HTBX)

Heat Biologics Inc (NASDAQ: HTBX) has grabbed attention from the analysts when it experienced a change of 16.55% in the last trading session to close at $1.69. A total of 7,516,751 shares exchanged hands during the intra-day trade contrast with its average trading volume of 1.52M shares, while its relative volume stands at 5.35. Relative volume is the comparison of current volume to average volume for the same time of day, and it’s displayed as a ratio. If RVOL is less than 1 it is not In Play on this trading day and Investors may decide not to trade it.  If RVOL is above 2 it is In Play and this is more evidence Investors ought to be in the name.  When stocks are *very* In Play one can see a RVOL of 5 and above.  The higher the RVOL the more In Play the stock is.

Day traders strive to make money by exploiting minute price movements in individual assets (usually stocks, though currencies, futures, and options are traded as well), usually leveraging large amounts of capital to do so, therefore they trade on Stocks in Play. In Play Stocks are volatile enough to produce good risk and reward trading opportunities for both bull and bear traders intraday. Most company stocks have very little volatility. They generally move extremely slowly and they only produce big price swings when the company produces good or bad trading results, which may only happen a couple of times a year at best.

In deciding what to focus on – in a stock, say – a typical day trader looks for three things: liquidity, volatility and trading volume. Liquidity allows an investor to enter and exit a stock at a good price (i.e. tight spreads, or the difference between the bid and ask price of a stock, and low slippage, or the difference between the predictable price of a trade and the actual price). If a stock does not have good liquidity then it may take some time before a broker is able to negotiate a deal to buy or sell a stock and the broker may not be able to get the sell or buy price that the trader is looking for. This is a problem for day traders and it could mean the difference between a profitable and non-profitable trade.

Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. 100,000 shares traded per day would be a minimum for most traders and some require 1,000,000.

Trading volume is a gauge of how many times a stock is bought and sold in a given time period (most commonly, within a day of trading, known as the average daily trading volume – ADTV). A high degree of volume indicates a lot of interest in a stock. Often, a boost in the volume of a stock is a harbinger of a price jump, either up or down.

Volatility is simply a measure of the predictable daily price range—the range in which a day trader operates. More volatility means greater profit or loss. After a recent check, Heat Biologics Inc (NASDAQ: HTBX) stock is found to be 7.54% volatile for the week, while 16.75% volatility is recorded for the month.

Technical’s Snapshot:

The stock has a market cap of $9.35M and the number of outstanding shares has been calculated 5.53M. Based on a recent bid, its distance from 20 days simple moving average is 13.79%, and its distance from 50 days simple moving average is 4.22% while it has a distance of -57.73% from the 200 days simple moving average. The company’s distance from 52-week high price is -78.58% and the current price is 55.05% away from 52-week low price. The company has Relative Strength Index (RSI 14) of 51.85 together with Average True Range (ATR 14) of 0.34.

Stock’s Valuation:

Past 5 years growth of HTBX observed at 17.00%, and for the next five years the analysts that follow this company is expecting its growth at N/A. The stock’s price to sales ratio for trailing twelve months is 6.23 and price to book ratio for the most recent quarter is 1.28, whereas price to cash per share for the most recent quarter are N/A. Its quick ratio for the most recent quarter is 1.10. Analysts mean recommendation for the stock is 1.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.

Disclaimer: Any news, report, research, and analysis published on are only for information purposes. Alpha Beta Stock (ABS) makes sure to keep the information up to date and correct, but we didn’t suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. Information in this release is fact checked and produced by competent editors of Alpha Beta Stock; however, human error can exist.

This post was originally published on *this site*